The global blood purification equipment market size surpassed US$ 10.2 Bn in 2019 and to reach US$ 22.6 billion by 2027 with a CAGR of 7.3% from 2021 to 2027.
Rise in prevalence of diabetes and high blood pressure resulting in chronic kidney diseases and favorable reimbursement policies are anticipated to drive the global blood purification equipment market from 2020 to 2030. North America is expected to account for significant share of the global blood purification equipment market during the forecast period. This can be attributed to the growth of the market in the U.S., owing to strong presence of market players and increase in patient population suffering from acute kidney disease and sepsis. Additionally, technological advancements and focus of market players on the development of cost-effective equipment for blood purification is likely to boost the market in the country.
Moreover, increase in the number of people suffering from COVID-19 infections and rise in number of people reaching the critical phase requiring blood purification contribute to North America’s dominance of the global blood purification equipment market during the forecast period. The market in Asia Pacific is projected to expand at a high CAGR of 8.1% from 2020 to 2030. This can be ascribed to the growth of the healthcare sector in countries such as China, Japan, and India. Moreover, increase in the geriatric population, rise in the number of people suffering from kidney diseases, and focus of leading players on strengthening presence in the emerging markets are anticipated to propel the market in the region during the forecast period.
Favorable Government Reimbursement Policies to Propel Market
Governments of various countries across the world provide reimbursement for dialysis procedures. The total government expenditure is US$ 57.1 Bn per year for approximately 2,600,000 patients on dialysis across the world. According to recent studies, Medicare reimburses around US$ 240 to US$ 255 per dialysis treatment. Medicare’s spending on kidney failure patients stood at US$ 35 Bn in 2016. Hemodialysis care costs the Medicare system an average of US$ 90,000 per patient annually in the U.S. for a total of US$ 28 Bn. Few countries in Asia Pacific also have reimbursement policies for dialysis procedures for patients suffering from chronic kidney diseases. For instance, the Government of South Korea reimburses 90% of the total dialysis cost. The Government of Japan provides 100% reimbursement to patients for dialysis procedures. Hence, favorable reimbursement schemes in various countries help patients to meet the high expenses involved with dialysis procedures, which is expected to drive the global blood purification equipment market during the forecast period.
Dialysis to Dominate Market
In terms of type, the global blood purification equipment market has been divided into dialysis, CRRT, hemoperfusion, and others (plasma exchange and immunoadsorption). High cost of the devices, increase in the number of dialyzers sold annually, and rise in prevalence of kidney diseases among the population are likely to propel the segment during the forecast period.
Portable to be Highly Attractive Product Type
Based on product type, the global blood purification equipment market has been bifurcated into portable and stationary. The portable segment is projected to dominate the global blood purification equipment market during the forecast period due to a number of advantages, including the ease of movement and less space utilized, and preferred by professionals for continuous blood purification process.
High Prevalence Rate of Acute Kidney Injury to Drive Market
In terms of application, the global blood purification equipment market has been classified into sepsis, COVID-19, infectious diseases, acute kidney injury, and others. The acute kidney injury segment is anticipated to dominate the global blood purification equipment market during the forecast period due to increase in the global burden of acute kidney injury (AKI). According to BMC Nephrology, around 13.3 million people across the world are estimated to be affected by acute kidney injury (AKI) annually, 85% of these live in developing countries.
Dialysis Centers to be Major End Users
Based on end user, the global blood purification equipment market has been categorized into hospitals & clinics, dialysis centers, and others. The dialysis centers segment is expected to constitute significant share of the global blood purification equipment market by 2030. The segment dominated the global market owing to rise in prevalence of chronic kidney disease (CKD) and increase in number of dialysis centers across the globe.
Key Segments
Regional Outlook
Competition Landscape in Blood Purification Equipment Market
The report also provides profiles of leading players operating in the global blood purification equipment market. These include Cytosorbents Corporation, Baxter International, Inc., ExThera Medical Corporation, Aethlon Medical, Inc., Fresenius SE & Co. KGaA, Cerus Corporation, Jafron Biomedical Co., Ltd., Spectra Medical, Inc., B. Braun Melsungen AG, and Nikkiso CO, Ltd.
Market Segmentation
By Type
By Product Type
By Application
By End User
By Region
Scope of the Report
VRR’s report on the blood purification equipment market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market over the forecast period from 2020 to 2027. The report provides the overall revenue of the global blood purification equipment market for the period 2020–2027, considering 2020 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global blood purification equipment market for the forecast period 2020–2027.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global blood purification equipment market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomena in the global blood purification equipment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global blood purification equipment market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global blood purification equipment market
The report also delves into the competition landscape of the global blood purification equipment market. Key players operating in the global blood purification equipment market are identified and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global blood purification equipment market that are profiled in this report.
Key Questions Answered in Blood Purification Equipment Market Report
Research Objectives and Research Approach
The comprehensive report on the global blood purification equipment market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of line of procedure for the blood purification equipment market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global blood purification equipment market in terms of type, product type, application, end user, and region. Key segments under each criteria are studied at length and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global blood purification equipment market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.1.1. Blood Purification Equipment Market
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Blood Purification Equipment Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Pricing Analysis
5.2. Technological Advancements
5.3. Epidemiology of Sepsis by Country/Region
5.4. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Blood Purification Equipment Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2018–2030
6.3.1. Dialysis
6.3.2. CRRT
6.3.3. Hemoperfusion
6.3.4. Others
6.4. Market Attractiveness Analysis, by Type
7. Global Blood Purification Equipment Market Analysis and Forecast, by Product Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Product Type, 2018–2030
7.3.1. Portable
7.3.2. Stationary
7.4. Market Attractiveness Analysis, by Product Type
8. Global Blood Purification Equipment Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2018–2030
8.3.1. Sepsis
8.3.2. COVID-19
8.3.3. Infectious Diseases
8.3.4. Acute Kidney Injury
8.3.5. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Blood Purification Equipment Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2019–2030
9.3.1. Hospitals & Clinics
9.3.2. Dialysis Centers
9.3.3. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Blood Purification Equipment Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Country/Region
11. North America Blood Purification Equipment Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value & Volume Forecast, by Type, 2018–2030
11.2.1. Dialysis
11.2.2. CRRT
11.2.3. Hemoperfusion
11.2.4. Others
11.3.Market Value Forecast, by Product Type, 2018–2030
11.3.1. Portable
11.3.2. Stationary
11.4.Market Value Forecast, by Application, 2018–2030
11.4.1. Sepsis
11.4.2. COVID-19
11.4.3. Infectious Diseases
11.4.4. Acute Kidney Injury
11.4.5. Others
11.5.Market Value Forecast, by End-user, 2018–2030
11.5.1. Hospitals & Clinics
11.5.2. Dialysis Centers
11.5.3. Others
11.6.Market Value Forecast, by Country, 2018–2030
11.6.1. U.S.
11.6.2. Canada
11.7.Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Product Type
11.7.3. By Application
11.7.4. By End-user
12. Europe Blood Purification Equipment Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value & Volume Forecast, by Type, 2018–2030
12.2.1. Dialysis
12.2.2. CRRT
12.2.3. Hemoperfusion
12.2.4. Others
12.3.Market Value Forecast, by Product Type, 2018–2030
12.3.1. Portable
12.3.2. Stationary
12.4.Market Value Forecast, by Application, 2018–2030
12.4.1. Sepsis
12.4.2. COVID-19
12.4.3. Infectious Diseases
12.4.4. Acute Kidney Injury
12.4.5. Others
12.5.Market Value Forecast, by End-user, 2018–2030
12.5.1. Hospitals & Clinics
12.5.2. Dialysis Centers
12.5.3. Others
12.6.Market Value Forecast, by Country/Sub-region, 2018–2030
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7.Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Product Type
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Blood Purification Equipment Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value & Volume Forecast, by Type, 2018–2030
13.2.1. Dialysis
13.2.2. CRRT
13.2.3. Hemoperfusion
13.2.4. Others
13.3.Market Value Forecast, by Product Type, 2018–2030
13.3.1. Portable
13.3.2. Stationary
13.4.Market Value Forecast, by Application, 2018–2030
13.4.1. Sepsis
13.4.2. COVID-19
13.4.3. Infectious Diseases
13.4.4. Acute Kidney Injury
13.4.5. Others
13.5.Market Value Forecast, by End-user, 2018–2030
13.5.1. Hospitals & Clinics
13.5.2. Dialysis Centers
13.5.3. Others
13.6.Market Value Forecast, by Country/Sub-region, 2018–2030
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7.Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Product Type
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Blood Purification Equipment Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2.Market Value & Volume Forecast, by Type, 2018–2030
14.2.1. Dialysis
14.2.2. CRRT
14.2.3. Hemoperfusion
14.2.4. Others
14.3.Market Value Forecast, by Product Type, 2018–2030
14.3.1. Portable
14.3.2. Stationary
14.4.Market Value Forecast, by Application, 2018–2030
14.4.1. Sepsis
14.4.2. COVID-19
14.4.3. Infectious Diseases
14.4.4. Acute Kidney Injury
14.4.5. Others
14.5.Market Value Forecast, by End-user, 2018–2030
14.5.1. Hospitals & Clinics
14.5.2. Dialysis Centers
14.5.3. Others
14.6.Market Value Forecast, by Country/Sub-region, 2018–2030
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7.Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Product Type
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Blood Purification Equipment Market Analysis and Forecast
15.1.Introduction
15.1.1. Key Findings
15.2.Market Value & Volume Forecast, by Type, 2018–2030
15.2.1. Dialysis
15.2.2. CRRT
15.2.3. Hemoperfusion
15.2.4. Others
15.3.Market Value Forecast, by Product Type, 2018–2030
15.3.1. Portable
15.3.2. Stationary
15.4.Market Value Forecast, by Application, 2018–2030
15.4.1. Sepsis
15.4.2. COVID-19
15.4.3. Infectious Diseases
15.4.4. Acute Kidney Injury
15.4.5. Others
15.5.Market Value Forecast, by End-user, 2018–2030
15.5.1. Hospitals & Clinics
15.5.2. Dialysis Centers
15.5.3. Others
15.6.Market Value Forecast, by Country/Sub-region, 2018–2030
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7.Market Attractiveness Analysis
15.7.1. By Type
15.7.2. By Product Type
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1.Market Player - Competition Matrix (by tier and size of companies)
16.2.Market Ranking Analysis, by Company, 2019
16.3. Company Profiles
16.3.1. Cytosorbents Europe GmbH
16.3.1.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2.Product Portfolio
16.3.1.3.SWOT Analysis
16.3.1.4.Strategic Overview
16.3.2. Baxter
16.3.2.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2.Product Portfolio
16.3.2.3.SWOT Analysis
16.3.2.4.Strategic Overview
16.3.3. Exthera Medical
16.3.3.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2.Product Portfolio
16.3.3.3.SWOT Analysis
16.3.3.4.Strategic Overview
16.3.4. Aethlon Medical, Inc.
16.3.4.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2.Product Portfolio
16.3.4.3.SWOT Analysis
16.3.4.4.Strategic Overview
16.3.5. Fresenius Medical Care
16.3.5.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2.Product Portfolio
16.3.5.3.SWOT Analysis
16.3.5.4.Strategic Overview
16.3.6. Cerus Corp Company
16.3.6.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2.Product Portfolio
16.3.6.3.SWOT Analysis
16.3.6.4.Strategic Overview
16.3.7. Jafron
16.3.7.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2.Product Portfolio
16.3.7.3.SWOT Analysis
16.3.7.4.Strategic Overview
16.3.8. NxStage Medical, Inc.
16.3.8.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2.Product Portfolio
16.3.8.3.SWOT Analysis
16.3.8.4.Strategic Overview
16.3.9. Spectral Medical, Inc.
16.3.9.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2.Product Portfolio
16.3.9.3.SWOT Analysis
16.3.9.4.Strategic Overview
16.3.10. Kaneka Corporation
16.3.10.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2.Product Portfolio
16.3.10.3.SWOT Analysis
16.3.10.4.Strategic Overview
16.3.11. B. Braun Melsungen AG
16.3.11.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2.Product Portfolio
16.3.11.3.SWOT Analysis
16.3.11.4.Strategic Overview
16.3.12. Nikkiso Co, Inc.
16.3.12.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2.Product Portfolio
16.3.12.3.SWOT Analysis
16.3.12.4.Strategic Overview